Ligand-specific dynamics of the androgen receptor at its response element in living cells

被引:88
作者
Klokk, Tove I.
Kurys, Piotr
Elbi, Cem
Nagaich, Akhilesh K.
Hendarwanto, Anindya
Slagsvold, Thomas
Chang, Ching-Yi
Hager, Gordon L.
Saatcioglu, Fahri
机构
[1] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway
[2] NCI, Lab Receptor Biol & Gene Express, Bethesda, MD 20892 USA
[3] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA
关键词
D O I
10.1128/MCB.01297-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Androgens have key roles in normal physiology and in male sexual differentiation as well as in pathological conditions such as prostate cancer. Androgens act through the androgen receptor (AR), which is a ligand-modulated transcription factor. Antiandrogens block AR function and are widely used in disease states, but little is known about their mechanism of action in vivo. Here, we describe a rapid differential interaction of AR with target genomic sites in living cells in the presence of agonists which coincides with the recruitment of BRM ATPase complex and chromatin remodeling, resulting in transcriptional activation. In contrast, the interaction of antagonist-bound or mutant AR with its target was found to be kinetically different: it was dramatically faster, occurred without chromatin remodeling, and resulted in the lack of transcriptional inhibition. Fluorescent resonance energy transfer analysis of wild-type AR and a transcriptionally compromised mutant at the hormone response element showed that intramolecular interactions between the N and C termini of AR play a key functional role in vivo compared to intermolecular interactions between two neighboring ARs. These data provide a kinetic and mechanistic basis for regulation of gene expression by androgens and antiandrogens in living cells.
引用
收藏
页码:1823 / 1843
页数:21
相关论文
共 86 条
[1]   GR and HMGB1 interact only within chromatin and influence each other's residence time [J].
Agresti, A ;
Scaffidi, P ;
Riva, A ;
Caiolfa, VR ;
Bianchi, ME .
MOLECULAR CELL, 2005, 18 (01) :109-121
[2]   The role of antiandrogen monotherapy in the treatment of prostate cancer [J].
Anderson, J .
BJU INTERNATIONAL, 2003, 91 (05) :455-461
[3]   Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens [J].
Avancès, C ;
Georget, V ;
Térouanne, B ;
Orio, F ;
Cussenot, O ;
Mottet, N ;
Costa, P ;
Sultan, C .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 184 (1-2) :13-24
[4]   Dynamic behavior of transcription factors on a natural promoter in living cells [J].
Becker, M ;
Baumann, C ;
John, S ;
Walker, DA ;
Vigneron, M ;
McNally, JG ;
Hager, GL .
EMBO REPORTS, 2002, 3 (12) :1188-1194
[5]   TISSUE-SPECIFIC DNASEI HYPERSENSITIVE SITES IN THE 5'-FLANKING SEQUENCES OF THE TRYPTOPHAN OXYGENASE AND THE TYROSINE AMINOTRANSFERASE GENES [J].
BECKER, P ;
RENKAWITZ, R ;
SCHUTZ, G .
EMBO JOURNAL, 1984, 3 (09) :2015-2020
[6]   Nuclear receptors: A rendezvous for chromatin remodeling factors [J].
Belandia, B ;
Parker, MG .
CELL, 2003, 114 (03) :277-280
[7]   Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR) [J].
Berrevoets, CA ;
Umar, A ;
Trapman, J ;
Brinkmann, AO .
BIOCHEMICAL JOURNAL, 2004, 379 :731-738
[8]   Structural basis for antagonism and resistance of bicalutamide in prostate cancer [J].
Bohl, CE ;
Gao, WQ ;
Miller, DD ;
Bell, CE ;
Dalton, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (17) :6201-6206
[9]  
Bourachot B, 1999, MOL CELL BIOL, V19, P3931
[10]  
BRACCI U, 1979, EUR UROL, V5, P303